Corcept Therapeutics Inc (NASDAQ: CORT) kicked off on Tuesday, up 10.49% from the previous trading day, before settling in for the closing price of $55.31. Over the past 52 weeks, CORT has traded in a range of $20.84-$62.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 12.18%. While this was happening, its average annual earnings per share was recorded 44.68%. With a float of $90.25 million, this company’s outstanding shares have now reached $104.70 million.
The extent of productivity of a business whose workforce counts for 352 workers is very important to gauge. In terms of profitability, gross margin is 98.44%, operating margin of 22.81%, and the pretax margin is 26.46%.
Corcept Therapeutics Inc (CORT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Corcept Therapeutics Inc is 13.87%, while institutional ownership is 82.26%. The most recent insider transaction that took place on Jan 10 ’25, was worth 111,188. In this transaction Director of this company sold 2,200 shares at a rate of $50.54, taking the stock ownership to the 0 shares. Before that another transaction happened on Jan 10 ’25, when Company’s Director proposed sale 2,200 for $50.54, making the entire transaction worth $111,188.
Corcept Therapeutics Inc (CORT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 44.68% per share during the next fiscal year.
Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators
Take a look at Corcept Therapeutics Inc’s (CORT) current performance indicators. Last quarter, stock had a quick ratio of 3.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.19. Likewise, its price to free cash flow for the trailing twelve months is 44.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.26, a number that is poised to hit 0.38 in the next quarter and is forecasted to reach 1.91 in one year’s time.
Technical Analysis of Corcept Therapeutics Inc (CORT)
The latest stats from [Corcept Therapeutics Inc, CORT] show that its last 5-days average volume of 0.83 million was superior to 0.77 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 99.12%. Additionally, its Average True Range was 2.39.
During the past 100 days, Corcept Therapeutics Inc’s (CORT) raw stochastic average was set at 96.16%, which indicates a significant decrease from 98.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.00% in the past 14 days, which was higher than the 44.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $55.14, while its 200-day Moving Average is $39.55. Now, the first resistance to watch is $62.93. This is followed by the second major resistance level at $64.76. The third major resistance level sits at $68.27. If the price goes on to break the first support level at $57.59, it is likely to go to the next support level at $54.08. Assuming the price breaks the second support level, the third support level stands at $52.25.
Corcept Therapeutics Inc (NASDAQ: CORT) Key Stats
The company with the Market Capitalisation of 6.40 billion has total of 104,775K Shares Outstanding. Its annual sales at the moment are 482,380 K in contrast with the sum of 106,140 K annual income. Company’s last quarter sales were recorded 182,550 K and last quarter income was 47,210 K.
